Organogenesis Holdings (ORGO) Amortization of Deferred Charges (2018 - 2026)

Organogenesis Holdings' Amortization of Deferred Charges history runs 9 years deep, the most recent figure standing at $91000.0 for Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 31.88% year-over-year to $91000.0 in Q1 2026; TTM through Mar 2026 was $397000.0, a 122.82% increase from a year earlier, with the FY2025 full-year figure at $375000.0, down 4.82% from the prior year.
• Amortization of Deferred Charges advanced to $91000.0 in Q1 2026 per ORGO's latest filing, from -$5.8 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $6.1 million in Q3 2025 and bottomed at -$5.8 million in Q4 2025.
• The 5-year median for Amortization of Deferred Charges is $108000.0 (2022), against an average of $551588.2.
• Across the five-year window, Amortization of Deferred Charges surged 1958.88% in 2024 and sank 7282.72% in 2025, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $108000.0 in 2022, then soared by 1862.04% to $2.1 million in 2023, then slumped by 96.18% to $81000.0 in 2024, then sank by 7282.72% to -$5.8 million in 2025, then soared by 101.56% to $91000.0 in 2026.
• Per Business Quant, the three latest ORGO Amortization of Deferred Charges figures stand at $91000.0 (Q1 2026), -$5.8 million (Q4 2025), and $6.1 million (Q3 2025).